DK3331495T3 - Flydende polymerleveringssystem til forlænget indgivelse af lægemidler - Google Patents
Flydende polymerleveringssystem til forlænget indgivelse af lægemidler Download PDFInfo
- Publication number
- DK3331495T3 DK3331495T3 DK16751437.1T DK16751437T DK3331495T3 DK 3331495 T3 DK3331495 T3 DK 3331495T3 DK 16751437 T DK16751437 T DK 16751437T DK 3331495 T3 DK3331495 T3 DK 3331495T3
- Authority
- DK
- Denmark
- Prior art keywords
- medicines
- delivery system
- liquid polymer
- polymer delivery
- extended administration
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 239000007788 liquid Substances 0.000 title 1
- 229920000642 polymer Polymers 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562200198P | 2015-08-03 | 2015-08-03 | |
| US201662275407P | 2016-01-06 | 2016-01-06 | |
| PCT/US2016/045334 WO2017024027A1 (en) | 2015-08-03 | 2016-08-03 | Liquid polymer delivery system for extended administration of drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3331495T3 true DK3331495T3 (da) | 2020-12-14 |
Family
ID=56684769
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16751437.1T DK3331495T3 (da) | 2015-08-03 | 2016-08-03 | Flydende polymerleveringssystem til forlænget indgivelse af lægemidler |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US10786515B2 (da) |
| EP (2) | EP3804698B1 (da) |
| JP (1) | JP6949820B2 (da) |
| KR (1) | KR20180030413A (da) |
| CN (1) | CN107920988B (da) |
| AU (1) | AU2016302252B2 (da) |
| BR (1) | BR112018002414B1 (da) |
| CA (1) | CA2994704A1 (da) |
| DK (1) | DK3331495T3 (da) |
| EA (1) | EA036951B1 (da) |
| ES (1) | ES2836805T3 (da) |
| HK (1) | HK1255638A1 (da) |
| HR (1) | HRP20201991T1 (da) |
| HU (1) | HUE052832T2 (da) |
| IL (1) | IL257221B (da) |
| MX (1) | MX2018001499A (da) |
| PT (1) | PT3331495T (da) |
| TW (1) | TWI718168B (da) |
| WO (1) | WO2017024027A1 (da) |
| ZA (1) | ZA201800591B (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1984009T1 (sl) | 2006-01-18 | 2013-02-28 | Qps, Llc | Farmacevtski sestavki z izboljĺ ano stabilnostjo |
| CA2994704A1 (en) | 2015-08-03 | 2017-02-09 | Tolmar International Limited | Liquid polymer delivery system for extended administration of drugs |
| KR102051808B1 (ko) | 2018-07-23 | 2019-12-04 | 주식회사 종근당 | 테스토스테론 운데카노에이트를 포함하는 안정한 약제학적 조성물 |
| AU2019348739A1 (en) | 2018-09-25 | 2021-04-22 | Tolmar International, Ltd. | Liquid polymer delivery system for extended administration of drugs |
| CN109966557A (zh) * | 2018-12-05 | 2019-07-05 | 博志生物科技有限公司 | 局部缓释Abaloparatide或相关多肽的GelMA水凝胶的制备方法及应用 |
| ES2966371T3 (es) | 2019-09-30 | 2024-04-22 | Tolmar International Ltd | Composiciones poliméricas líquidas y sistemas para el aporte prolongado de péptidos como ingredientes farmacéuticos activos |
| CN110946826B (zh) * | 2019-12-12 | 2022-02-22 | 烟台大学 | 一种利奥西呱口服制剂及其制备方法 |
| WO2022069996A1 (en) | 2020-09-30 | 2022-04-07 | Tolmar International Limited | Biodegradable polymer and solvent compositions and systems for extended storage and delivery of active pharmaceutical ingredients |
| WO2024117740A1 (ko) * | 2022-11-28 | 2024-06-06 | 동국제약 주식회사 | 인-시튜 임플란트를 형성할 수 있는 서방형 약학 조성물 및 이의 제조방법 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938763B1 (en) | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| US6197320B1 (en) * | 1994-03-11 | 2001-03-06 | Shalaby W. Shalaby | Absorbable E-caprolactone polymers and medical devices |
| US5668288A (en) * | 1996-04-16 | 1997-09-16 | Depuy Orthopaedics, Inc. | Polyester ionomers for implant fabrication |
| US6565874B1 (en) * | 1998-10-28 | 2003-05-20 | Atrix Laboratories | Polymeric delivery formulations of leuprolide with improved efficacy |
| US8470359B2 (en) | 2000-11-13 | 2013-06-25 | Qlt Usa, Inc. | Sustained release polymer |
| US20090092650A1 (en) * | 2004-12-15 | 2009-04-09 | Warren Stephen L | Sustained Delivery Formulations of Octreotide Compounds |
| SI1984009T1 (sl) * | 2006-01-18 | 2013-02-28 | Qps, Llc | Farmacevtski sestavki z izboljĺ ano stabilnostjo |
| AR070033A1 (es) * | 2007-11-06 | 2010-03-10 | Panacea Biotec Ltd | Composiciones inyectables, sus procesos y usos |
| US20090181068A1 (en) * | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
| US8946277B2 (en) | 2008-04-18 | 2015-02-03 | Warsaw Orthopedic, Inc. | Clonidine formulations in a biodegradable polymer carrier |
| CA2749997A1 (en) * | 2009-01-23 | 2010-07-29 | Surmodics Pharmaceuticals, Inc. | Polymer mixtures comprising polymers having different non-repeating units and methods for making and using same |
| GB2513267B (en) * | 2010-06-08 | 2015-03-18 | Rb Pharmaceuticals Ltd | Injectable flowable composition comprising buprenorphine |
| CN103228444A (zh) * | 2010-11-04 | 2013-07-31 | 新日铁住金化学株式会社 | 带有硬涂层的聚碳酸酯 |
| DK2717914T3 (da) * | 2011-06-10 | 2020-01-20 | Ramscor Inc | Depotformuleringer til administration af proteiner til øjet og fremgangsmåder til fremstilling deraf |
| CN107252498B (zh) * | 2011-10-17 | 2021-02-19 | 聚合-医药有限公司 | 可吸收的原位凝胶形成系统、其制备方法及用途 |
| CA2994704A1 (en) | 2015-08-03 | 2017-02-09 | Tolmar International Limited | Liquid polymer delivery system for extended administration of drugs |
-
2016
- 2016-08-03 CA CA2994704A patent/CA2994704A1/en active Pending
- 2016-08-03 ES ES16751437T patent/ES2836805T3/es active Active
- 2016-08-03 MX MX2018001499A patent/MX2018001499A/es unknown
- 2016-08-03 EA EA201890436A patent/EA036951B1/ru unknown
- 2016-08-03 JP JP2018506344A patent/JP6949820B2/ja active Active
- 2016-08-03 EP EP20205445.8A patent/EP3804698B1/en active Active
- 2016-08-03 EP EP16751437.1A patent/EP3331495B1/en active Active
- 2016-08-03 BR BR112018002414-7A patent/BR112018002414B1/pt active IP Right Grant
- 2016-08-03 DK DK16751437.1T patent/DK3331495T3/da active
- 2016-08-03 CN CN201680045838.XA patent/CN107920988B/zh active Active
- 2016-08-03 KR KR1020187005376A patent/KR20180030413A/ko active IP Right Grant
- 2016-08-03 HU HUE16751437A patent/HUE052832T2/hu unknown
- 2016-08-03 AU AU2016302252A patent/AU2016302252B2/en active Active
- 2016-08-03 WO PCT/US2016/045334 patent/WO2017024027A1/en active Application Filing
- 2016-08-03 US US15/749,030 patent/US10786515B2/en active Active
- 2016-08-03 PT PT167514371T patent/PT3331495T/pt unknown
- 2016-08-03 TW TW105124656A patent/TWI718168B/zh active
-
2018
- 2018-01-29 ZA ZA2018/00591A patent/ZA201800591B/en unknown
- 2018-01-29 IL IL257221A patent/IL257221B/en unknown
- 2018-11-20 HK HK18114774.3A patent/HK1255638A1/zh unknown
-
2020
- 2020-08-17 US US16/995,020 patent/US11779589B2/en active Active
- 2020-12-11 HR HRP20201991TT patent/HRP20201991T1/hr unknown
-
2023
- 2023-08-09 US US18/446,687 patent/US20240066039A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3714922T3 (da) | Anordning til subkutan indgivelse af flydende lægemiddel | |
| DK3331495T3 (da) | Flydende polymerleveringssystem til forlænget indgivelse af lægemidler | |
| DK3484547T3 (da) | Dosisdetekteringsmodul til medicinindgivelsesanordning | |
| DK3368108T3 (da) | Medikamenttilførselsanordning | |
| DK3139986T3 (da) | System til administration af terapeutisk gas | |
| DK3294382T3 (da) | Injektionsanordning til administration af et væskeformigt medikament | |
| DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
| DK3337539T3 (da) | Medikamenttilførselsanordning til variable enkeltdoser | |
| DK3357491T3 (da) | Farmaceutisk sammensætning til afgivelse af et anionisk medikament | |
| DK3479819T3 (da) | Stabilt væskeformigt farmaceutisk præparat | |
| DK3244948T3 (da) | Bestemmelse af medikamentdosis | |
| DK3419700T3 (da) | Indretning til dosiskontrol af indretning til afgivelse af injicerbar lægemiddel | |
| DK3380154T3 (da) | Anordning til injektion af lægemidler | |
| DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
| DK3378482T3 (da) | Formulering til administration af antitumorlægemiddel | |
| DK3310800T3 (da) | Leveringssystem til styret lægemiddelfrigivelse | |
| DK3245988T3 (da) | System til ultralydsforstærket transskleral levering af lægemidler | |
| DK3099356T3 (da) | Medikamentadministrationsanordning | |
| EP3260148A4 (en) | Liquid drug administration device | |
| DK3380146T3 (da) | Medikamentadministrationsanordning | |
| DK3380139T3 (da) | Medikamentadministrationsanordning | |
| DK3325081T3 (da) | Fremgangsmåder til lymfatisk levering af aktive stoffer | |
| DK3280474T3 (da) | Indretning til levering af nasalt medikament | |
| DK3021911T3 (da) | Anordning til indgivelse af lægemidler | |
| DK2981258T3 (da) | Farmaceutiske formuleringer til subkutan indgivelse af furosemid |